Oncology Billing · Indiana

Oncology billing and revenue cycle for Indiana providers.

Indiana operates 359 oncology billing organizations registered in NPPES, representing 2.6 percent of the U.S. oncology billing footprint. Indiana is a mid-sized oncology billing market. Oncology revenue cycle complexity centers on infusion administration code stacking, drug J-code and ASP+6 reimbursement, NCCN-aligned prior authorization, and oncology-specific E/M leveling. Indiana oncology practices need RCM partners with deep infusion + drug billing experience.

359
NPPES orgs in IN
2.6%
of US market
#14
national rank
90%+
Realization target
Last updated: May 31, 2026 · Authored by ASP-RCM Solutions Team

What good oncology billing execution looks like for Indiana providers.

The Indiana oncology billing market has its own quirks. Here is the operating discipline we install on every Indiana engagement.

  1. Infusion and chemotherapy administration code accuracyOncology infusion billing requires precise capture of initial, sequential, concurrent, and additional hour codes (96360-96376, 96401-96450, J-codes for drugs). Indiana infusion centers leak revenue on undercoded administration time.
  2. J-code drug pricing and ASP+6 reimbursementOncology drugs reimburse under Medicare at Average Sales Price + 6 percent (Part B), with similar logic on many commercial. Indiana oncology practices need accurate J-code billing, NDC reporting, and ASP-aware revenue forecasting.
  3. Prior authorization for oncology drugsSpecialty oncology drugs require payer prior authorization, often with clinical criteria tied to NCCN guideline alignment. PA automation tuned for oncology compresses access-to-treatment time and reduces denials.
  4. E/M leveling for oncology visitsOncology visits qualify for higher E/M levels under MDM complexity rules. Indiana oncology practices that under-level E/M leave significant revenue uncollected.
  5. OCM and Enhancing Oncology Model participationPractices in the CMS Enhancing Oncology Model (EOM) coordinate clinical, financial, and reporting workflows for value-based payment. Indiana EOM participants need RCM that flows into program reporting.
  6. 340B drug pricing for eligible oncology entitiesFQHC + DSH-eligible hospital oncology practices in 340B require precise inventory tracking, contract pharmacy coordination, and proper claim modification (TB modifier).

More Midwest state guides.

Sister Midwest state pages for oncology billing.

FAQ: oncology billing in Indiana.

How many oncology billing providers operate in Indiana?

NPPES lists 359 oncology billing organizations in Indiana, representing 2.6% of the U.S. footprint. Top concentrations are in Indianapolis (56), Evansville (19), Munster (18).

Does Indiana Health Coverage Programs (IHCP) cover oncology billing services?

Yes. Indiana Health Coverage Programs (IHCP) covers oncology billing services for eligible beneficiaries, with plan-specific authorization rules and rate structures that vary by year.

What commercial payers cover oncology billing in Indiana?

All major national commercial payers cover oncology billing in Indiana, including UnitedHealthcare/Optum, Aetna, Cigna/Evernorth, the dominant Indiana Blue Cross Blue Shield plan, and (where active) Humana.

Does ASP-RCM serve oncology billing providers in Indiana?

Yes. ASP-RCM Solutions provides oncology billing and revenue cycle services for providers in Indiana and across all 50 states. Senior partners on every account. Request a free 30-day audit.

How do I get started?

Request a free 30-day RCM audit. We assess your current state, identify revenue leakage, and produce a written prioritized recommendations list.

Free 30-day audit for Indiana oncology billing providers.

Send us your last 90 days of claim data. We will send back a 4-page audit with prioritized recommendations and dollar estimates.

Request audit Talk to a senior partner